Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Accrued Expenses and Long-term Liabilities

6 Months Ended

Jun. 30, 2016

7.	ACCRUED EXPENSES AND LONG-TERM LIABILITIES

Other accrued expenses consisted of the following as of June 30, 2016 and December 31, 2015:

	June 30, 2016		December 31, 2015
Facilities realignment accrual	$	-	$	43
Self insurance accruals		41		137
Indemnification liability		875		875
Contingent consideration		376		659
Rent payable		104		127
DOJ settlement		750		250
Accrued professional fees		987		775
Taxes payable		648		591
Unclaimed property		544		546
All others		1,722		1,958
	$	6,047	$	5,961

Long-term liabilities consisted of the following as of June 30, 2016 and December 31, 2015:

	June 30, 2016		December 31, 2015
Rent payable	$	-	$	52
Uncertain tax positions		3,512		3,425
DOJ settlement (indemnified by RedPath)		1,000		2,500
Other		201		201
	$	4,713	$	6,178